Medical Management of Chronic Myelogenous Leukemia

This valuable reference provides a timely summary of current therapies for chronic myelogenous leukemia (CML), discussing both basic pathophysiology and new experimental strategies.
Combining the insights of over 30 prominent researchers in the field, Medical Management of Chronic Myelogenous Leukemia
compares interferon therapy with conventional chemotherapy
covers chronic, accelerated, and Philadelphia-negative phases
details standard therapy with IFN- regimens and allogenic stem cell transplantation
describes the utility and limitations of CML animal models
profiles clinical trials testing IFN in combination with other agents
assesses improvements in survival times among CML patients
reviews the effectiveness of Southern blot monitoring
traces the development of oligonucleotides as potential therapeutic agents
outlines therapy with monoclonal antibodies, targeted NK cells, and immune T cells
and more!
Containing over 1500 references, tables, drawings, and photographs, Medical Management of Chronic Myelogenous Leukemia is suitable for clinical oncologists, hematologists, immunologists and researchers in the fields of tumor immunology and cancer immunotherapy, internists, and residents, fellows, and medical school students in these disciplines.